GGrantIndex
Sort

25,944 grants matching neurodegeneration

Validating the New Criteria for Preclinical Alzheimer's disease

$507,281
Clifford Jack · Mayo Clinic Rochester · R01 · FY2015 · AG

Temporal control of mitochondrial mutagenesis

$507,234
Marc Vermulst · University Of Southern California · R01 · FY2022 · AG

Molecular and genetic studies of NMNAT2 in neuroprotection

$507,169
Hui-Chen Lu · Trustees Of Indiana University · R01 · FY2024 · NS

Overcoming the Inhibitory Neurovascular Niche in Preterm Infant Brain Injury

$507,079
Mark A Petersen · University Of California, San Francisco · R01 · FY2025 · NS

CAREER: Multiscale modeling of perivascular flow in the brain

$506,798
Jessica Shang · University Of Rochester · · FY2021 · ENG

Identifying symptomatic and neuroprotective strategies for cereballar ataxia

$506,768
Vikram Govindaraju Shakkottai · Ut Southwestern Medical Center · R01 · FY2021 · NS

Discovering How Cu(II)/Zn(II) Uptake by the Prion Protein Controls Structure, Function and Neurotoxicity

$506,759
Glenn L Millhauser · University Of California Santa Cruz · R35 · FY2024 · GM

A Longitudinal Analysis Stream for FreeSurfer

$506,694
Bruce Fischl · Massachusetts General Hospital · R01 · FY2014 · NS

Molecular pathways leading to neurodegeneration in vivo

$506,685
Brian J Bacskai · Massachusetts General Hospital · R01 · FY2015 · AG

Environmental Metals, Excitotoxicity and ALS

$506,648
William D Atchison · Michigan State University · R01 · FY2019 · ES

Gene Therapy for Neurodegenerative Lysosomal Storage Diseases

$506,598
Miguel S Esteves · Univ Of Massachusetts Med Sch Worcester · R01 · FY2012 · HD

Electron Spin Relaxation in Model Membranes

$506,514
Jack H Freed · Cornell University · R01 · FY2017 · GM

Targeting Histone K4 Methylation for Treatment of Alzheimer's Disease and Related Dementia

$506,436
Zhen Yan · State University Of New York At Buffalo · R01 · FY2020 · AG

Targeting Histone K4 Methylation for Treatment of Alzheimer's Disease and Related Dementia

$506,436
Zhen Yan · State University Of New York At Buffalo · R01 · FY2021 · AG

Targeting Histone K4 Methylation for Treatment of Alzheimer's Disease and Related Dementia

$506,436
Zhen Yan · State University Of New York At Buffalo · R01 · FY2019 · AG

Targeting Histone K4 Methylation for Treatment of Alzheimer's Disease and Related Dementia

$506,436
Zhen Yan · State University Of New York At Buffalo · R01 · FY2023 · AG

Targeting Histone K4 Methylation for Treatment of Alzheimer's Disease and Related Dementia

$506,436
Zhen Yan · State University Of New York At Buffalo · R01 · FY2022 · AG

Role of mTORC1 in Retinal Ganglion Cell Physiology and Disease

$506,423
Steve F Abcouwer · University Of Michigan At Ann Arbor · R01 · FY2022 · EY

Role of mTORC1 in Retinal Ganglion Cell Physiology and Disease

$506,423
Steve F Abcouwer · University Of Michigan At Ann Arbor · R01 · FY2021 · EY

Modulating Energy Metabolism as a Therapeutic Approach for Alzheimer's Disease

$506,324
M Flint Beal · Winifred Masterson Burke Med Res Inst · P01 · FY2016 · AG

a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease

$506,300
Robert A Rissman · University Of California, San Diego · R01 · FY2017 · AG

a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease

$506,300
Robert A Rissman · University Of California, San Diego · R01 · FY2021 · AG

a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease

$506,300
Robert A Rissman · University Of California, San Diego · R01 · FY2019 · AG

a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease

$506,300
Robert A Rissman · University Of California, San Diego · R01 · FY2018 · AG

a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease

$506,300
Robert A Rissman · University Of California, San Diego · R01 · FY2020 · AG